Biote Q2 EPS $(0.25) Misses $0.09 Estimate, Sales $49.26M Beat $46.76M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biote reported Q2 losses of $(0.25) per share, missing the analyst consensus estimate of $0.09 by 377.78 percent. However, the company's quarterly sales of $49.26 million beat the analyst consensus estimate of $46.76 million by 5.34 percent.
August 10, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biote's Q2 earnings per share missed estimates, but sales exceeded expectations.
While Biote's earnings per share missed estimates, which could negatively impact the stock, the company's sales exceeded expectations, which could have a positive effect. The net impact on the stock is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100